Pharma Cite SRL
2.3 FTEThe score of Pharma Cite shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Cite's annual accounts
| 2025 | |
|---|---|
| Net result | −10,995 € |
| Equity | −10,995 € |
| Cash | 44,334 € |
| EBITDA | 36,755 € |
| Total assets | 705,229 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
Pharma Cite's financial analysis
- Solvency-1.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Cite
Pharma Cite's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.644.825
- VAT number
- BE1016644825
- Peppol
- Registered · 0208:1016644825 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 2024
- Registered office
- 6110 Montigny-le-Tilleul
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Cite (SRL) has been based in Montigny-le-Tilleul since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 10,995 € and equity of −10,995 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -1.6%, below the median of its sector (41.5%).
Companies similar to Pharma Cite
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Bekaert Retail sale of pharmaceutical products Ichtegem · balance sheet 705,473 €
- Meer Apotheek Retail sale of pharmaceutical products Hoogstraten · balance sheet 705,802 €
- Farmacie AN -Jolie Retail sale of pharmaceutical products Tongeren · balance sheet 705,804 €
- Verstraete Christine Apotheek Retail sale of pharmaceutical products Destelbergen · balance sheet 706,487 €
- Pharmacie Marsin Retail sale of pharmaceutical products Flémalle · balance sheet 706,613 €
- Apopharma Retail sale of pharmaceutical products Wezembeek-Oppem · balance sheet 702,319 €
- West Pharma Retail sale of pharmaceutical products Anderlecht · balance sheet 701,649 €
- Mepharma Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet 701,340 €
Frequently asked questions about Pharma Cite
What is the revenue of Pharma Cite?
Pharma Cite files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Cite?
In Belgium, the VAT number is the company number prefixed with BE: BE1016644825 for Pharma Cite, if the company is VAT-registered. Its company number (CBE) is 1016.644.825.
Where is the registered office of Pharma Cite?
According to the CBE register, the registered office of Pharma Cite is in 6110 Montigny-le-Tilleul.
What is the equity of Pharma Cite?
At the close of the 2025 financial year, the equity of Pharma Cite amounts to -10,995 €, a solvency of -1.6% of total assets.
How many people work at Pharma Cite?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Cite?
The register lists 2 active mandates at Pharma Cite. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Cite
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →